Demonstrate and Deliver Value with Powerful Clinical and Economic Evidence

As the understanding of the molecular basis of disease grows, so will the availability of novel tests that will offer disease screening and risk assessment, guide therapy selection, and monitor therapy response in individual patients. Boston Healthcare broadly supports innovation in advanced diagnostics and laboratory services by developing strategic approaches to go-to-market, market access, reimbursement, and value communication.  In the world of value-based healthcare, diagnostics are poised to play an outsized role in delivering clinical and economic impact.  This presents and extraordinary opportunity that innovators must be prepared to capture.

Demonstrate and Deliver Value with Powerful Clinical and Economic Evidence

As the understanding of the molecular basis of disease grows, so will the availability of novel tests that will offer disease screening and risk assessment, guide therapy selection, and monitor therapy response in individual patients. Boston Healthcare broadly supports innovation in advanced diagnostics and laboratory services by developing strategic approaches to go-to-market, market access, reimbursement, and value communication.  In the world of value-based healthcare, diagnostics are poised to play an outsized role in delivering clinical and economic impact.  This presents and extraordinary opportunity that innovators must be prepared to capture.

Focus Areas

  • In Vitro Diagnostics
  • Companion Diagnostics
  • Proprietary Labratory Analyses

Solutions

  • Market Assessment and Strategy
  • Reimbursement and Evidence Development Strategy
  • Heath Economics Modeling and Publication Support

Clinical Applications

  • Screening
  • Diagnosis
  • Prognosis
  • Monitoring

Conditions | Diseases

  • Cancer
  • Infectious Disease
  • Carrier and Newborn Screening
  • Inherited and Rare Diseases
  • Autoimmune Diseases

Platforms

  • Immunoassay
  • Clinical Chemistry
  • Anatomic Pathology
  • Mass Spectrometry
  • PCR
  • NGS
  • Liquid Biopsy
  • Digital Pathology
  • Point of Care
  • Informatics | AI Solutions

Case Studies

US Market Access and Commercialization Planning for Novel Genomic Test

US Market Access and Commercialization Planning for Novel Genomic Test-1

Create. Navigate. Grow. Achieve.